Search research articles
Contact Us
Filters
Showing results (41-50 of 46) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 46 results.
The Lancet. Respiratory Medicine
|
March 25, 2026
Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial
Stacy Todd, Joanne Euden, Jennifer Condie, et al.
Blood
|
November 14, 2025
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18
Steven Knapper, Laura W Dillon, Malavika Babu, et al.
Leukemia
|
January 23, 2024
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, et al.
Blood Advances
|
May 22, 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First Relapse
Niek G Van Der Maas, Dimitri A Breems, Clara P W Klerk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2024
Risk Stratification in Older Intensively Treated Patients With AML
Jurjen Versluis, Marlen Metzner, Ariel Wang, et al.
Global Change Biology
|
May 4, 2026
Bridging the Energy Balance Gap in Eddy-Covariance Measurements: Insights From Standardized Network Data
Giacomo Nicolini, David Durden, Luca Di Fiore, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 46) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 46 results.
The Lancet. Respiratory Medicine
|
March 25, 2026
Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled, open-label, phase 3 trial
Stacy Todd, Joanne Euden, Jennifer Condie, et al.
Blood
|
November 14, 2025
CPX-351 versus daunorubicin, cytarabine plus gemtuzumab ozogamicin in older adults with non-adverse risk AML: NCRI AML18
Steven Knapper, Laura W Dillon, Malavika Babu, et al.
Leukemia
|
January 23, 2024
Clinical evaluation of complete remission (CR) with partial hematologic recovery (CRh) in acute myeloid leukemia: a report of 7235 patients from seven cohorts
Jacob S Appelbaum, Andrew H Wei, Sumithra J Mandrekar, et al.
Blood Advances
|
May 22, 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First Relapse
Niek G Van Der Maas, Dimitri A Breems, Clara P W Klerk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 4, 2024
Risk Stratification in Older Intensively Treated Patients With AML
Jurjen Versluis, Marlen Metzner, Ariel Wang, et al.
Global Change Biology
|
May 4, 2026
Bridging the Energy Balance Gap in Eddy-Covariance Measurements: Insights From Standardized Network Data
Giacomo Nicolini, David Durden, Luca Di Fiore, et al.
Page
of 5